› Forums › General Melanoma Community › GSK Drugs
- This topic has 6 replies, 2 voices, and was last updated 12 years, 7 months ago by
Tim–MRF.
- Post
-
- July 9, 2013 at 1:50 pm
GSK just submitted an application to the FDA for their two new melanoma drugs to be used in combination. This is a BRAF inhibitor, dabrafenib, and a MEK inhibitor, trametinib. Studies have shown that these drugs work better in combination than either do alone. I think most people expected they would be prescribed in combination, but getting this approval, if it is approved, will help smooth conversations about off-label usage and reimbursement.
GSK just submitted an application to the FDA for their two new melanoma drugs to be used in combination. This is a BRAF inhibitor, dabrafenib, and a MEK inhibitor, trametinib. Studies have shown that these drugs work better in combination than either do alone. I think most people expected they would be prescribed in combination, but getting this approval, if it is approved, will help smooth conversations about off-label usage and reimbursement.
Tim–MRF
- Replies
-
-
- July 9, 2013 at 2:35 pm
That is teriffic news, Tim! Thank you!
Is there anything we can do to assist or speed the approval process? Write to the FDA? Check with our insurance companies to find out if they will pay for the simulatneous administration of both drugs if the combo is NOT FDA approved? (A strong inducement to approve the combo, in my opinion.) Anything?
-
- July 9, 2013 at 2:35 pm
That is teriffic news, Tim! Thank you!
Is there anything we can do to assist or speed the approval process? Write to the FDA? Check with our insurance companies to find out if they will pay for the simulatneous administration of both drugs if the combo is NOT FDA approved? (A strong inducement to approve the combo, in my opinion.) Anything?
-
- July 9, 2013 at 2:35 pm
That is teriffic news, Tim! Thank you!
Is there anything we can do to assist or speed the approval process? Write to the FDA? Check with our insurance companies to find out if they will pay for the simulatneous administration of both drugs if the combo is NOT FDA approved? (A strong inducement to approve the combo, in my opinion.) Anything?
-
- July 9, 2013 at 4:27 pm
-
- July 9, 2013 at 4:27 pm
-
- July 9, 2013 at 4:27 pm
-
- You must be logged in to reply to this topic.